Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - Impax Laboratories, LLC | c10749exv99w1.htm |
EX-99.2 - EXHIBIT 99.2 - Impax Laboratories, LLC | c10749exv99w2.htm |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 4, 2011
Impax Laboratories,
Inc.
(Exact name of registrant as
specified in its charter)
Delaware | 001-34263 | 65-0403311 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
30831 Huntwood Avenue,
Hayward, CA |
94544 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (510) 476-2000
Not
Applicable |
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On January 4, 2011, Impax Laboratories, Inc. (the “Company”) issued a press release announcing it will present at the J.P. Morgan 29th Annual Healthcare Conference on Monday, January 10th. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
A copy of the materials that the Company presented at the J.P. Morgan Healthcare Conference is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) |
Exhibits.
|
The following exhibits are furnished herewith.
Exhibit No. | Description | |
99.1
|
Press Release issued January 4, 2011. | |
99.2
|
J.P. Morgan Healthcare Conference Presentation. |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 10, 2011
IMPAX LABORATORIES, INC.
By: /s/
Arthur A. Koch,
Jr.
Name:
Arthur A. Koch, Jr.
Title: Senior Vice President, Finance, and
Chief
Financial Officer
2
EXHIBIT INDEX
Exhibit No. | Description | |
99.1
|
Press Release issued January 4, 2011. | |
99.2
|
J.P. Morgan Healthcare Conference Presentation. |
3